VXRT Vaxart, Inc.
Healthcare$0.64-0.86%ClosedMarket Cap: $153.2M
As of 2026-05-26
Valuation
P/E (TTM)
9.17
PEG
0.07
P/B
1.64
P/S
0.61
EV/EBITDA
2.37
DCF Value
$-34.02
FCF Yield
9.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
14.9%
Net Margin
14.5%
ROE
61.4%
ROA
20.6%
ROIC
35.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $39.2M | 100.0% | $5.2M | $5.2M | $— | — |
| Q4 null | $104.2M | 100.0% | $55.4M | $55.0M | $— | — |
| FY null | $237.3M | 100.0% | $18.1M | $16.3M | $— | — |
| Q3 null | $72.4M | 100.0% | $-7.8M | $-8.1M | $— | — |
| Q2 null | $39.7M | 100.0% | $-14.6M | $-15.0M | $— | — |
| Q1 null | $20.9M | 100.0% | $-14.9M | $-15.6M | $— | — |
| Q4 null | $15.2M | 100.0% | $-11.5M | $-12.0M | $— | — |
| FY null | $28.7M | 100.0% | $-66.3M | $-66.9M | $— | — |
| Q3 null | $4.9M | 100.0% | $-14.5M | $-14.1M | $— | — |
| Q2 null | $6.4M | 100.0% | $-16.3M | $-16.5M | $— | — |
| Q1 null | $2.2M | 100.0% | $-24.1M | $-24.4M | $— | — |
| Q4 2023 | $3.2M | 63.0% | $-16.9M | $-17.4M | $-0.04 | — |